{"id":2510,"date":"2024-03-28T02:07:16","date_gmt":"2024-03-28T02:07:16","guid":{"rendered":"https:\/\/healthynewsusa.com\/?p=2510"},"modified":"2024-03-28T02:07:19","modified_gmt":"2024-03-28T02:07:19","slug":"at-stake-in-mifepristone-case-abortion-fdas-authority-and-return-to-1873-obscenity-law","status":"publish","type":"post","link":"https:\/\/healthynewsusa.com\/?p=2510","title":{"rendered":"At Stake in Mifepristone Case: Abortion, FDA\u2019s Authority, and Return to 1873 Obscenity Law"},"content":{"rendered":"
Lawyers from the conservative Christian group that won the case to overturn Roe v. Wade<\/em> are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: shutting down access to abortion pills for women across the country.<\/p>\n The case challenges the FDA\u2019s regulation of mifepristone, a prescription-only drug approved in 2000 with a stellar safety record<\/a> that is used in 63% of all U.S. abortions<\/a>.<\/p>\n Viewed across decades of anti-abortion activism, the case brought by the Alliance Defending Freedom represents a \u201cmoonshot\u201d couched in technical arguments about pharmaceutical oversight and the resuscitation of an 1873 anti-obscenity law. A victory would lay the groundwork for a de facto nationwide abortion ban.<\/p>\n